Your session is about to expire
← Back to Search
Brain Stimulation + Motor Training for Spinal Cord Injury
N/A
Recruiting
Led By Monica A Perez, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic disease, Any debilitating disease prior to the SCI that caused exercise intolerance, Premorbid, ongoing major depression or psychosis, altered cognitive status, History of head injury or stroke, Pacemaker, Metal plate in skull, History of seizures, Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold, Pregnant females, Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal cord disease such as spinal stenosis, spina bifida, MS, or herniated disk
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post treatment at minute 0, minute 10, minute30, minute 60.
Awards & highlights
No Placebo-Only Group
Summary
This trial will study how best to help people with cervical spinal cord injuries regain grasping ability through non-invasive brain stimulation, motor training, and other methods.
Who is the study for?
This trial is for right-handed adults aged 18-85, both healthy and those with chronic spinal cord injury (SCI) at C8 or above. Healthy participants must be able to grip and move their wrists. SCI participants need some wrist movement and the ability to grip, but can't join if they have uncontrolled medical issues, a history of severe mental health problems, head injury or stroke, pacemakers, metal in the skull, seizure history, certain medications lowering seizure threshold or are pregnant.
What is being tested?
The study tests how brain stimulation (iTMS) combined with motor tasks affects grasping function after cervical SCI. Participants will practice precision and power grips while receiving either real iTMS or a sham treatment without actual stimulation. The goal is to see if this combination improves hand function.
What are the potential side effects?
Potential side effects from iTMS may include discomfort at the stimulation site on the scalp, headache, lightheadedness or seizures although rare. Training might cause muscle fatigue or soreness.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have uncontrolled health issues or a history of major mental health, head injury, stroke, seizures, or specific spinal cord diseases.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post treatment at minute 0, minute 10, minute30, minute 60.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post treatment at minute 0, minute 10, minute30, minute 60.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes in amplitude of Motor evoked potential size
Secondary study objectives
Grip Strength and 9-hole peg test
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Active Control
Group I: Experiment 1bActive Control2 Interventions
To accomplish this aim the investigators propose to complete one main experiment. The investigators will use iTMS and/or an acoustic startle stimuli to test the hypothesis that induced-plasticity protocols (iTMS and startle stimuli) will enhance EMG and force output in hand muscles during grasping. In a randomized sham crossover design, SCI and controls will be assigned to two groups: (1) iTMS applied during precision and power grip (two randomized sessions), and (2) startle applied during precision and power grip (two randomized sessions).
Group II: Experiment 2Active Control4 Interventions
To accomplish this aim the investigators propose to complete one main experiment. The investigators will combine iTMS and/or acoustic startle with precision and power grip training to test the hypothesis that 'precision and power grip training outcomes will be enhanced by iTMS and startle induced plasticity'. In a randomized sham controlled design, SCI and control subjects will be assigned to: training+iTMS and training+sham iTMS and training+startle and training+sham startle.
Group III: Experiment 1aActive Control2 Interventions
Examine physiological mechanisms contributing to the control of precision and power grip behaviors. To accomplish this aim the investigators propose to complete one main experiment. The investigators will test the hypotheses that there are two fundamentally distinct modes of hand operation after SCI. One involves brainstem pathways, and permits whole-hand 'power grip', while the other involves corticospinal and motor cortical connections, and allows a wide range of fractionated finger movements (precision grip) after SCI. Measurements of corticospinal, reticulospinal, and motoneuron excitability will be tested during index finger abduction, precision and power grip.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,666 Previous Clinical Trials
3,765,634 Total Patients Enrolled
Monica A Perez, PhDPrincipal InvestigatorEdward Hines Jr. VA Hospital, Hines, IL
3 Previous Clinical Trials
188 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have uncontrolled health issues or a history of major mental health, head injury, stroke, seizures, or specific spinal cord diseases.I am a healthy right-handed person aged 18-85, able to grip and move my wrists fully.I am between 18-85 years old with a spinal cord injury above C8, can grip with one hand, and have some wrist movement.I am 18-85 with a spinal cord injury above C8, can feel light touch and pin prick, and can grip with one hand.I am 18-85 years old, right-handed, and can grip and move my wrists normally.
Research Study Groups:
This trial has the following groups:- Group 1: Experiment 1b
- Group 2: Experiment 2
- Group 3: Experiment 1a
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.